These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
178 related articles for article (PubMed ID: 28867658)
1. Identification and characterization of a potent and biologically-active PDE4/7 inhibitor via fission yeast-based assays. de Medeiros AS; Wyman AR; Alaamery MA; Allain C; Ivey FD; Wang L; Le H; Morken JP; Habara A; Le C; Cui S; Lerner A; Hoffman CS Cell Signal; 2017 Dec; 40():73-80. PubMed ID: 28867658 [TBL] [Abstract][Full Text] [Related]
2. Inhibition of PDE3B augments PDE4 inhibitor-induced apoptosis in a subset of patients with chronic lymphocytic leukemia. Moon E; Lee R; Near R; Weintraub L; Wolda S; Lerner A Clin Cancer Res; 2002 Feb; 8(2):589-95. PubMed ID: 11839681 [TBL] [Abstract][Full Text] [Related]
3. Cyclic nucleotide phosphodiesterase profiling reveals increased expression of phosphodiesterase 7B in chronic lymphocytic leukemia. Zhang L; Murray F; Zahno A; Kanter JR; Chou D; Suda R; Fenlon M; Rassenti L; Cottam H; Kipps TJ; Insel PA Proc Natl Acad Sci U S A; 2008 Dec; 105(49):19532-7. PubMed ID: 19033455 [TBL] [Abstract][Full Text] [Related]
4. New classes of PDE7 inhibitors identified by a fission yeast-based HTS. Alaamery MA; Wyman AR; Ivey FD; Allain C; Demirbas D; Wang L; Ceyhan O; Hoffman CS J Biomol Screen; 2010 Apr; 15(4):359-67. PubMed ID: 20228279 [TBL] [Abstract][Full Text] [Related]
5. Comparative assessment of PDE 4 and 7 inhibitors as therapeutic agents in experimental autoimmune encephalomyelitis. González-García C; Bravo B; Ballester A; Gómez-Pérez R; Eguiluz C; Redondo M; Martínez A; Gil C; Ballester S Br J Pharmacol; 2013 Oct; 170(3):602-13. PubMed ID: 23869659 [TBL] [Abstract][Full Text] [Related]
6. A yeast-based chemical screen identifies a PDE inhibitor that elevates steroidogenesis in mouse Leydig cells via PDE8 and PDE4 inhibition. Demirbas D; Wyman AR; Shimizu-Albergine M; Cakici O; Beavo JA; Hoffman CS PLoS One; 2013; 8(8):e71279. PubMed ID: 23967182 [TBL] [Abstract][Full Text] [Related]
7. Type 4 cAMP phosphodiesterase (PDE4) inhibitors augment glucocorticoid-mediated apoptosis in B cell chronic lymphocytic leukemia (B-CLL) in the absence of exogenous adenylyl cyclase stimulation. Tiwari S; Dong H; Kim EJ; Weintraub L; Epstein PM; Lerner A Biochem Pharmacol; 2005 Feb; 69(3):473-83. PubMed ID: 15652238 [TBL] [Abstract][Full Text] [Related]
8. Development of a fission yeast-based high-throughput screen to identify chemical regulators of cAMP phosphodiesterases. Ivey FD; Wang L; Demirbas D; Allain C; Hoffman CS J Biomol Screen; 2008 Jan; 13(1):62-71. PubMed ID: 18227226 [TBL] [Abstract][Full Text] [Related]
9. Use of a Fission Yeast Platform to Identify and Characterize Small Molecule PDE Inhibitors. Hoffman CS Front Pharmacol; 2021; 12():833156. PubMed ID: 35111072 [TBL] [Abstract][Full Text] [Related]
10. Multiple cAMP Phosphodiesterases Act Together to Prevent Premature Oocyte Meiosis and Ovulation. Vigone G; Shuhaibar LC; Egbert JR; Uliasz TF; Movsesian MA; Jaffe LA Endocrinology; 2018 May; 159(5):2142-2152. PubMed ID: 29608743 [TBL] [Abstract][Full Text] [Related]
11. Effects of selective inhibition of PDE4 and PDE7 on airway reactivity and cough in healthy and ovalbumin-sensitized guinea pigs. Mokry J; Joskova M; Mokra D; Christensen I; Nosalova G Adv Exp Med Biol; 2013; 756():57-64. PubMed ID: 22836619 [TBL] [Abstract][Full Text] [Related]
12. Type 4 cyclic adenosine monophosphate phosphodiesterase as a therapeutic target in chronic lymphocytic leukemia. Kim DH; Lerner A Blood; 1998 Oct; 92(7):2484-94. PubMed ID: 9746789 [TBL] [Abstract][Full Text] [Related]
13. Inhibition of type 4 cyclic nucleotide phosphodiesterase blocks intracellular TLR signaling in chronic lymphocytic leukemia and normal hematopoietic cells. Tan Y; Watkins AA; Freeman BB; Meyers JA; Rifkin IR; Lerner A J Immunol; 2015 Jan; 194(1):101-12. PubMed ID: 25416804 [TBL] [Abstract][Full Text] [Related]
14. Inhibition of PDE3, PDE4 and PDE7 potentiates glucocorticoid-induced apoptosis and overcomes glucocorticoid resistance in CEM T leukemic cells. Dong H; Zitt C; Auriga C; Hatzelmann A; Epstein PM Biochem Pharmacol; 2010 Feb; 79(3):321-9. PubMed ID: 19737543 [TBL] [Abstract][Full Text] [Related]
15. Role of Phosphodiesterase 7 (PDE7) in T Cell Activity. Effects of Selective PDE7 Inhibitors and Dual PDE4/7 Inhibitors on T Cell Functions. Szczypka M Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32854348 [TBL] [Abstract][Full Text] [Related]
16. β-Adrenergic cAMP signals are predominantly regulated by phosphodiesterase type 4 in cultured adult rat aortic smooth muscle cells. Zhai K; Hubert F; Nicolas V; Ji G; Fischmeister R; Leblais V PLoS One; 2012; 7(10):e47826. PubMed ID: 23094097 [TBL] [Abstract][Full Text] [Related]
17. Use of a Schizosaccharomyces pombe PKA-repressible reporter to study cGMP metabolising phosphodiesterases. Demirbas D; Ceyhan O; Wyman AR; Ivey FD; Allain C; Wang L; Sharuk MN; Francis SH; Hoffman CS Cell Signal; 2011 Mar; 23(3):594-601. PubMed ID: 21118717 [TBL] [Abstract][Full Text] [Related]
18. Synthesis, Anti-inflammatory Activity and Docking Studies of Some Newer 1,3-Thiazolidine-2,4-dione Derivatives as Dual Inhibitors of PDE4 and PDE7. Sharma H; Lather V; Grewal AS; Pandita D Curr Comput Aided Drug Des; 2019; 15(3):225-234. PubMed ID: 30280674 [TBL] [Abstract][Full Text] [Related]
19. Phosphodiesterases do not limit beta1-adrenoceptor-mediated sinoatrial tachycardia: evidence with PDE3 and PDE4 in rabbits and PDE1-5 in rats. Kaumann AJ; Galindo-Tovar A; Escudero E; Vargas ML Naunyn Schmiedebergs Arch Pharmacol; 2009 Nov; 380(5):421-30. PubMed ID: 19693491 [TBL] [Abstract][Full Text] [Related]
20. Phosphodiesterase inhibitors in airways disease. Fan Chung K Eur J Pharmacol; 2006 Mar; 533(1-3):110-7. PubMed ID: 16458289 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]